New User? Click here to register

New drugs and options in MBC: Are there drugs that must be offered to patients in 2023?

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

October 20, 2023

Joseph GLIGOROV
MD, PHD Medical Oncologist, Paris, France

What is the difference between molecular typing and liquid biopsy?
Simon NAYLER
pathologist, Johanesburgh, South Africa
How can AI help us decode multi-Omics data to improve breast cancer treatment?
Aaron HAN
pathologist, Dubai, UAE
Radiotherapy management of bone metastasis.

Bruno CUTULI
Radiotherapist, Reims, France
AI-Powered Image Analysis for Breast Cancer
Gregory LENCZNER
Premalignant lesions: When to avoid open surgery?
Foucauld CHAMMING’S